Tue, Jul 22, 2014, 3:30 PM EDT - U.S. Markets close in 30 mins.

Recent

% | $
Click the to save as a favorite.

NuPathe Inc. Message Board

  • drjwater drjwater Nov 18, 2013 10:39 AM Flag

    Anyone notice that we went from $8 target to $6.50

     

    So it looks like we have increased from 1 analysts to 3 analysts and their average price target is $6.50. Funny how they have great growth and only $23 million sales for next years 3rd quarter. That is only what less than 200,000 units/quarter for the 3rd quarter of next year? Well we should see this start moving up shorty.

    Also did anyone read the article about Novartis in the wall street journal today? Novartis is getting out of lower margin areas and plans on expanding it role in "market leading drugs". With Glivec losing patent protection one would wonder if they Novartis is going to start spending more cash in pharma market leading drugs? Also what kind of fit would Glivec have for Nupathe's transdermal patch? Not related just wondering.

    Sentiment: Strong Buy

    This topic is deleted.
 
PATH
4.25+0.07(+1.67%)Feb 21 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.